Hepatic fibrosis and its serum markers
Okabe, K.
Rinsho Byori. Japanese Journal of Clinical Pathology 40(12): 1258-1264
1992
ISSN/ISBN: 0047-1860 PMID: 1339165 Document Number: 403312
As serum markers for hepatitis fibrosis, prolyl hydroxylase (PH), type III procollagen peptide (PIIIP), type IV collagen, mesenchymal metalloproteinase (MMP), tissue inhibitor of metalloproteinase (TIMP) and laminin are reliable for clinical application. PH, PIIIP, MMP, TIMP and LM are regarded as the marker of ongoing hepatic fibrosis. Type IV collagen and LM are indicative for the extent of hepatic fibrosis.
Document emailed within 1 workday
Related Documents
Sasaki, N.; Ueno, T.; Morita, Y.; Nagata, E.; Sata, M. 2006: Usefulness of serum hepatic fibrosis markers in the diagnosis of nonalcoholic steatohepatitis (NASH) Hepato-Gastroenterology 53(71): 678-681Xie, S.-B.; Yao, J.-L.; Zheng, S.-S.; Yao, C.-L.; Zheng, R.-Q. 2002: The levels of serum fibrosis marks and morphometric quantitative measurement of hepatic fibrosis Hepatobiliary and Pancreatic Diseases International: Hbpd Int 1(2): 202-206
Tsukamoto, T.; Yamamoto, T.; Ikebe, T.; Takemura, S.; Shuto, T.; Kubo, S.; Hirohashi, K.; Kinoshita, H. 2004: Serum markers of liver fibrosis and histologic severity of fibrosis in resected liver Hepato-Gastroenterology 51(57): 777-780
Ghanem, M.H.; Guirgis, F.K.; el-Sawy, M. 1973: Serum glycoproteins in schistosomal hepatic fibrosis Journal of Tropical Medicine and Hygiene 76(1): 13-15
Gabr, Y.; Fouda, H.; Mahfouz, M.; Amin, E.S. 1973: Serum lipids in bilharzial hepatic fibrosis Acta Biologica et Medica Germanica 31(3): 407-413
Guo, J.-X.; Ma, H.-B.; Li, Y.-L.; Xu, J.; Yang, L.-H.; Shi, J.-B.; Li, B.; Liu, A.-X.; Li, X.-X.; Li, B.-A.; Mao, Y.-L. 2009: Evaluation of the ELISA and the enhanced chemiluminescence immunoassay in use to determine the serum markers for liver fibrosis Zhonghua Shi Yan he Lin Chuang Bing du Xue Za Zhi 23(1): 71-73
Ruiz del Arbol, L.; Moreira, V.F.; Pascasio, J.M.; González Martín, J.A.; Larraona, J.L.; Simón, M.A.; Suárez, E.; Barcena, R.; Bueno, R. 1985: Serum markers of hepatitis B virus infection in alcoholic hepatic disease Revista Clinica Espanola 177(8): 390-393
Shinkawa, H.; Takemura, S.; Minamiyama, Y.; Kodai, S.; Tsukioka, T.; Osada-Oka, M.; Kubo, S.; Okada, S.; Suehiro, S. 2009: S-allylcysteine is effective as a chemopreventive agent against porcine serum-induced hepatic fibrosis in rats Osaka City Medical Journal 55(2): 61-69
Gwak, G-Youn.; Kim, T.Hun.; Yu, S.Jong.; Yoon, J-Hwan.; Yong, J.Jung.; Park, S.Cheol.; Lee, H-Suk. 2007: Lack of association between serum leptin levels and hepatic steatosis, fibrosis or response to antiviral therapy in Korean chronic hepatitis C patients Hepato-Gastroenterology 54(75): 844-848
Takashima, T.; Iijma, H.; Nishiguchi, S. 2015: Diagnosis of liver fibrosis in patients with chronic hepatitis using serum enhanced liver fibrosis (ELF) Nihon Rinsho. Japanese Journal of Clinical Medicine 73(Suppl 9): 145-149
Poynard, T. 2005: Surrogate markers for liver fibrosis Medical Journal of Malaysia 60 Suppl B: 39-40
Fontaine, F.; Vasseur, F.; Savary, J.B.; Cousin, J.; Deminatti, M. 1986: Antenatal diagnosis of cystic fibrosis: value of DNA markers Presse Medicale 15(45): 2254
Iaquinto, G.; Maio, P.; Ambrosone, L.; Magliocca, M.; Taccone, W.; Imparato, L.; Rambaldi, M. 1998: Usefulness of fibrosis markers in liver diseases Italian Journal of Gastroenterology and Hepatology 30(2): 233-234
Angeles-Angeles, A.; Victoria-Peralta, P.A. 1988: Hepatic fibropolycystic disease (Caroli's disease and congenital hepatic fibrosis) Gaceta Medica de Mexico 124(9-10): 391-394
Iturriaga, H.; Bunot, D.; Pino, M.E.; Pérez, C.; Ugarte, G. 1983: Serum enzymes in the diagnosis of hepatic necrosis in alcoholics without hepatic insufficiency Revista Medica de Chile 111(10): 1003-1008
Kim, L.B.; Putiatina, A.N. 2010: Dynamics of biochemical markers of reparative fibrosis in uncomplicated course of myocardial infarction Kardiologiia 50(12): 10-14
Voss, R.; Hertz, B.; Chemke, J.; Katznelson, D.; Yahav, Y. 1988: Cystic fibrosis: linked DNA markers in prenatal diagnosis and carrier detection Harefuah 114(7): 317-320
Vaĺková, M. 2002: Pathophysiology of hepatic fibrosis Vnitrni Lekarstvi 48(1): 27-33
Topchii, I.; Semenovykh, P.; Galchiskaya, V.; Yakymenko, Y.; Shcherban, T. 2019: Association of Fibroblast Growth Factor 23 with Markers of Inflammation and Fibrosis in Diabetic Nephropathy Georgian Medical News 2019(292-293): 44-49
Baiget, M.; Casals, T.; Nunes, V.; Estivill, X. 1989: Detection of carriers and prenatal diagnosis of cystic fibrosis in Spanish families using DNA markers Medicina Clinica 92(10): 361-363